Safety of the Novel Vector Vaccine Against Brucella Abortus Based on Recombinant Influenza Viruses Expressing Brucella L7/L12 and OMP16 Proteins, in Cattle
Journal Title: Journal of Vaccines and Immunology - Year 2015, Vol 1, Issue 1
Abstract
This paper presents the results of a study of the safety of new vector vaccine against B. abortus based on recombinant influenza A subtype H5N1 or H1N1 (viral constructs vaccine formulation) viruses expressing Brucella ribosomal protein L7/L12 and Omp16, in cattle. To increase the effectiveness of the vaccine, adjuvants such as Montanide Gel01 or chitosan were included in its composition. Immunization of cattle (5 animals per group) with the viral constructs vaccine formulation only, or its combination with adjuvants Montanide Gel01 or chitosan, were conducted via the conjunctival method using cross prime (influenza virus subtype H5N1) and booster (influenza virus subtype H1N1) vaccination schedules. Vaccine candidates were evaluated in comparison with the positive (Brucella abortus) and negative (PBS) controls. Comprehensive studies involving thermometry and clinical examination, hematology and biochemical blood analysis, showed that all of the viral constructs vaccine formulation, as well as their combination with adjuvants, compared to the commercial bacterial vaccine Brucella abortus were completely safe in cattle. Furthermore it is shown that the developed vaccines can effectively differentiate vaccinated animals from infected animals.
Authors and Affiliations
Tabynov Kaissar, Kydyrbaye Zhailaubay, Ryskeldinova Sholpan, Yespembetov Bolat, Syrymkyzy Nazym, Akzhunusova Indira, Sansyzbay Abylai
Keywords
Related Articles
- EP ID EP553512
- DOI 10.17352/jvi.000001
- Views 49
- Downloads 0
Immunity against Pasteurella multocida in Animals Vaccinated with Inactivated Pasteurella multocida and Herbal Adjuvant ‘DIP-HIP’
Background: Haemorrhagic septicaemia (HS) is acute, highly contagious form of disease of water buffalo, cattle, and bison caused by Pasteurella multocida (PM). It is considered the most economically important bacterial d...
Prospects for the Development of a Dengue Vaccine
Dengue is a mosquito-borne viral disease which is currently an important and rapid growing health problem across the globe. Four closely related dengue serotypes cause the disease, which ranges from asymptomatic infectio...
Travel Vaccination
With increased globalization, the international boundaries between countries are diminished. Number of worldwide activities such as tourism, expansion of industry to multinational level, migrant employment, civilized eff...
Lethal Food-Induced Anaphylaxis in Children
Despite careful contributions, food allergic children have a significant risk of anaphylactic episodes. Especially at risk are children not accompanied by parents or caregivers in public places, or restaurants, or not pr...
Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus
Background: Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating a...